Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 16/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6871576 | 0.90 | ADORA2A (0.44) | ADORA2AADORA2BADORA1PDE11A | |
| SCHEMBL6863143 | 0.86 | ADORA2A (0.58) | ADORA2AADORA2BADORA1PDE11A | |
| SCHEMBL6871208 | 0.85 | F2 (0.39) | ADORA2AF2 | |
| SCHEMBL6867673 | 0.84 | ADORA2A (0.48) | ADORA2AADORA2BADORA1PDE11AF2 | |
| SCHEMBL6869890 | 0.84 | ADORA2A (0.48) | ADORA2AADORA2BADORA1PDE11AF2 | |
| SCHEMBL6863049 | 0.82 | ADORA2A (0.45) | ADORA2APDE11A | |
| SCHEMBL6868365 | 0.82 | ADORA2A (0.44) | ADORA2AADORA2BADORA1PDE11ACRHR1 | |
| SCHEMBL6870319 | 0.81 | ADORA2A (0.49) | ADORA2AADORA2BADORA1PDE11A | |
| SCHEMBL6869063 | 0.81 | ADORA2A (0.46) | ADORA2AADORA2BADORA1PDE11AF2 | |
| SCHEMBL6871315 | 0.81 | ADORA2A (0.50) | ADORA2APDE11ACRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1347974-B1 | AMINOTRIAZOLOPYRIDIINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | HOFFMANN LA ROCHE (CH) | 2004-11-03 | — | — | EP | disclosed |